Range
Dist8
WELL

WELL

Welltower Inc

$236.06+2.55%
Setup
Watch
Buy Zone
$239.65-$251.63
Sector
REIT - Healthcare Facilities
Industry
REIT - Healthcare Facilities
64
Recommendation
Extended
Watch

Setup may be valid but price is no longer in a clean buy zone.

WELL chart

Loading chart…
Overall Quality64
77
relative strength
50
Weak fund-Q
82
+22% vs avg
75
6/8 checks
91
REIT - Healthcare Facilities

Trade Plan

Extended
Entry
$239.65
Entry Zone
$239.65-$251.63
Stop / Risk
$220.48
RS Rating
77
Volume confirmed
Yes
Targets
$287.58 / $299.56

Breakout · IBD Setup

3 5
Entry $239.65–$251.63Stop $220.48Target $287.58 / $299.56
Market regimeRange
Quality64
RS Rating77
Above 50-MA+10.5%
Above 200-MA+19.65%
VolumeConfirmed
In Buy ZoneNo
Not extendedExtended
Invalidation · Close below stop

How this came together

64
MarketRange
SetupWatch
ConfidenceExperimental · not backtested
Fund-Q50 · Weak
StatusWatch

Stock Data

52-Week Range149 – 232
Price % Chg YTD27.18%
Price % Chg 4wk20.84%
50-Day Avg Vol3.4 Mil
P/E Ratio
Market Cap$160B
SectorReal Estate
IndustryREIT - Healthcare Facilities

Company Fundamentals

EPS % Chg (Qtr)34%
Sales % Chg (Qtr)38.21%
EPS Growth 5y-22.65%
Sales Growth 5y18.69%
Annual ROE3.62%
Gross Margin20.96%
Operating Margin5.24%
Net Margin-3.49%
Debt / Equity0.46

Setup levels

Current price
$236.06
Pivot
$239.65
Distance to buy
+1.8%
52-week range
148.97-231.84

Trigger evidence

No active trigger evidence available.
Pattern levels: near highs
Financial health checks
3/5
Return on equity above 15%

ROE 3.62%

Net margin above 10%

Net margin -3.49%

EPS growing quarter on quarter

EPS q/q 34%

Sales growing quarter on quarter

Sales q/q 38.21%

Debt to equity below 1.0

D/E 0.46

Key metrics

Finviz snapshot · value vs. sector median (≥5 peers)

Annual ROE3.62%
Net margin-3.49%
Gross margin20.96%
EPS growth q/q34%
Sales growth q/q38.21%
Debt / equity0.46
lower is better

Business quality

50
GradeWeak
EPS rating46
P/E
Market cap$160B
IndustryREIT - Healthcare Facilities

Technical checks

Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Pass
Volumen bestätigt
Pass
In Kaufzone
Fail
Nicht überextended
Fail
Über 21-EMA
Pass
Volumen gesund
Pass

IBD / source mentions

No recent IBD mention found for this ticker.

Signal history

Added to list
2026-06-27
Trigger date
Days on list
7

Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.